Shaolin Capital Management’s Peak Bio, Inc. Warrant PKBOW Stock Holding History

Shaolin Capital Management’s Portfolio PKBOW Stock Details PKBOW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-34,847	Closed	-$7K	–	859
2022 Q4	$7K	Sell	34,847 -7,439	-18%	-$1.39K	﹤0.01%	704
2022 Q3	$5K	Hold	42,286	–	–	﹤0.01%	901
2022 Q2	$9K	Sell	42,286 -2,714	-6%	-$870	﹤0.01%	924
2022 Q1	$16K	Buy	+45,000	New	+$19.3K	﹤0.01%	900

Other funds holding PKBOW

EFI

EHP Funds Inc Toronto, Canada $43.6M AUM 69.08% 1-Year Est. Return

CCM

Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return

Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return

Shaolin Capital Management's PKBOW Position: Q1 2023 in Review

Shaolin Capital Management sold out of Peak Bio, Inc. Warrant (PKBOW) in Q1 2023, closing a stake of 34,847 shares — an estimated $7K sold.

Shaolin Capital Management first reported a position in PKBOW in Q1 2022 and held it in 4 quarters. The position peaked at $16K in Q1 2022. 5 funds tracked by Wall St. Rank hold PKBOW as of Q1 2023.

Shaolin Capital Management reported no remaining Peak Bio, Inc. Warrant position as of Q1 2023 after selling out during the quarter.
Shaolin Capital Management sold 34,847 Peak Bio, Inc. Warrant shares in Q1 2023, an estimated $7K.
Shaolin Capital Management first reported a position in Peak Bio, Inc. Warrant in Q1 2022 and held it in 4 quarters.
Shaolin Capital Management's Peak Bio, Inc. Warrant position peaked at $16K in Q1 2022.
5 funds tracked by Wall St. Rank held Peak Bio, Inc. Warrant as of Q1 2023.

Based on Shaolin Capital Management's 13F filing for Q1 2023, filed 15 May 2023.